Products

Annalise Enterprise CTB Triage-OH
Annalise.ai
Neurology AI
Annalise Enterprise CTB Triage-OH is an FDA-cleared AI software tool designed to identify suspected obstructive hydrocephalus in non-contrast brain CT scans, aiding in worklist prioritization and accelerating critical diagnoses.
Annalise Enterprise CXR Triage Trauma
Annalise.ai
Radiology & Imaging AI
Annalise Enterprise CXR Triage Trauma is an FDA-cleared AI software tool that aids clinicians in the rapid assessment and triage of adult chest X-ray cases by identifying suspected radiological findings like pleural effusion and pneumoperitoneum, and up to 124 other findings, to optimize workflow and improve diagnostic accuracy.

See all 2 products →

About Annalise-AI

Annalise.ai is a leading healthcare AI company that specializes in developing comprehensive clinical decision-support solutions for medical imaging. Their mission is to redefine medical imaging through artificial intelligence, aiming to improve healthcare accessibility and outcomes globally. The company’s AI algorithms are trained on extensive, diverse datasets and validated by a large pool of qualified radiologists. [17]

For physicians, Annalise.ai’s solutions act as a “second set of digital eyes,” assisting with the interpretation of radiological imaging studies. [7, 8] Their flagship products, Annalise Enterprise CXR and Annalise Enterprise CTB, are designed to analyze chest X-rays and non-contrast head CT studies, respectively. [5, 7] These tools can detect a wide range of findings—124 for chest X-rays and 130 for head CTs—and prioritize critical cases, thereby optimizing radiology workflow, reducing diagnostic uncertainty, and enabling faster diagnoses and treatment pathways. [5, 7, 11, 17, 18] The company also offers Annalise Triage, an FDA-cleared worklist triage solution that rapidly monitors exams for time-sensitive critical findings and alerts clinicians. [8, 17, 18] Annalise.ai’s technology is deployed in over 1,000 sites across four continents and has regulatory clearance in over 40 countries, including the US, UK, Europe, and Asia. [5, 7, 11, 18]

Focus Areas

Medical imaging AI clinical triage radiology workflow automation deep learning for medical imaging multi-view and multi-modal imaging inference (CXR and CT) large-scale annotated dataset curation and model training regulatory clearance and health-technology designation for imaging software clinical systems integration (PACS/RIS) clinical deployment planning and reimbursement support

Business Intelligence

TechnologyDeep learning for medical imaging, multi-view and multi-modal imaging inference (CXR and CT), worklist prioritization and triage algorithms, low-latency inference engines, large-scale expert-annotated training datasets, radiology-focused foundational AI models, cloud-native (AWS cloud infrastructure)

What Physicians Need to Know

Medical Imaging AI & Radiology AI
Annalise-AI specializes in comprehensive AI solutions for medical imaging, particularly in radiology. Their products, Annalise Enterprise CXR and Annalise Enterprise CTB, are designed to assist clinicians in interpreting radiological studies by detecting a wide array of findings on chest X-rays (CXR) and non-contrast head CT scans (NCCTB).
Chest X-ray (CXR) Analysis
Annalise-AI's CXR solutions can detect up to 124 findings. Specifically, their Annalise Triage CXR is FDA-cleared for the detection and triage of pneumothorax, tension pneumothorax, pleural effusion, pneumoperitoneum, and vertebral compression fractures. Studies have shown high accuracy for pneumothorax detection (AUC > 0.97).
Non-Contrast Head CT Analysis
Their CTB solutions can detect up to 130 findings on non-contrast head CT scans. Annalise Triage Head CT is FDA-cleared for critical findings such as acute subdural/epidural hematoma, acute subarachnoid hemorrhage, intra-axial hemorrhage, intraventricular hemorrhage, obstructive hydrocephalus, mass effect, and vasogenic edema. Annalise-AI's obstructive hydrocephalus detection received FDA Breakthrough Device Designation.
AI-Assisted Triage and Notification (CADt)
A core specialization is AI-powered triage, which prioritizes time-sensitive findings in CXRs and NCCTBs to enhance diagnostic efficiency and patient outcomes. The system integrates with hospital image and order management systems to flag and prioritize suspicious cases for faster review.
Diagnostic Decision Support & Workflow Optimization
Annalise-AI provides comprehensive decision-support software that assists clinicians in interpreting radiological images, aiming to reduce 'near-misses' and improve efficiency by flagging critical cases. Their solutions can improve median report turnaround times by up to 39%.
Detection of Specific Conditions
Annalise-AI offers specialized detection for a range of critical conditions, including: pneumothorax and tension pneumothorax (with the unique ability to distinguish between them on CXR), pleural effusion, pneumoperitoneum, vertebral compression fracture (the only FDA-cleared device for VCF on CXR as of Nov 2024), acute subdural/epidural hematoma, acute subarachnoid hemorrhage, intra-axial hemorrhage, intraventricular hemorrhage, and obstructive hydrocephalus.
Physician Tip

Annalise-AI's solutions act as a 'second set of eyes' for radiologists, aiding in the early and accurate detection of critical conditions, especially during high imaging volumes or low staff coverage. The AI prioritizes urgent cases, streamlining worklists and potentially reducing report turnaround times, allowing physicians to focus on critical cases faster. While the AI provides valuable support and notifications, it is intended to assist clinicians and does not replace clinical decision-making. Physicians should cross-check subtle findings, particularly in areas like sulcal spaces or cisterns for SAH, as AI tools may have limitations in detecting these.

Annalise-AI's solutions integrate with existing hospital image and order management systems, such as PACS/RIS, and worklists (HL7/API), to process studies and provide notifications for prioritization. They also operate in parallel with standard clinical workflows.

Products by Annalise-AI

2 products in the directory

Annalise Enterprise CTB Triage-OH
Annalise.ai
Neurology AI
Annalise Enterprise CTB Triage-OH is an FDA-cleared AI software tool designed to identify suspected obstructive hydrocephalus in non-contrast brain CT scans, aiding in worklist prioritization and accelerating critical diagnoses.
Annalise Enterprise CXR Triage Trauma
Annalise.ai
Radiology & Imaging AI
Annalise Enterprise CXR Triage Trauma is an FDA-cleared AI software tool that aids clinicians in the rapid assessment and triage of adult chest X-ray cases by identifying suspected radiological findings like pleural effusion and pneumoperitoneum, and up to 124 other findings, to optimize workflow and improve diagnostic accuracy.

What the Web Says

Annalise.ai is a highly capable AI radiology system that assists clinicians in interpreting medical images like chest X-rays and CT scans. It's designed to integrate into existing hospital workflows, triage worklists, and highlight critical findings, acting as a decision-support tool rather than a replacement for radiologists. The company has received positive feedback for its ability to improve diagnostic accuracy and efficiency in various global healthcare settings.

Overall: Positive

Strengths

  • Detects a high number of findings on chest X-rays and CT scans (up to 124 for CXR and 130 for CTB).
  • Integrates cleanly into existing hospital PACS and RIS workflows.
  • Improves diagnostic accuracy and efficiency for radiologists.
  • Reduces human bias and minimizes the risk of misdiagnosis.
  • Offers comprehensive decision-support, covering many findings unlike some competitors.
  • Utilizes extensive and diverse training datasets, annotated by multiple radiologists, leading to fewer false positives.

Limitations

  • Not a consumer tool; sold directly to hospitals and radiology networks.
  • Pricing is not publicly available.
  • Some radiologists on Reddit have noted that the AI can miss things and overcall others, despite being helpful for confirmation.
  • Concerns raised on Reddit about the use of anonymized patient data for training without explicit patient knowledge.
  • Limited information available on employer reviews on common platforms like Glassdoor or Capterra.

Based on reviews from: The AI Directory, Slashdot, SourceForge, Harrison.ai, AuntMinnie, Reddit, Medical Technology Enterprise Consortium (MTEC)

Last updated: 2026-10-22

Videos

News, demos, and interviews about Annalise-AI.

Loading videos...

Videos load interactively. If none appear, search YouTube for Annalise-AI →

View all on YouTube

Press & Coverage

Applied Radiology
Annalise.ai Rebrands as Harrison.ai Radiology in Move to Unify Global Imaging AI Platform
Annalise.ai has rebranded its radiology solutions under the name Harrison.ai Radiology to unify its global brand and simplify engagement for partners as it expands internationally. The company's AI-powered tools are used in over 1,000 clinical sites across 40+ countries.
2025-10
Harrison.ai
Annalise.ai Receives FDA Clearance and Breakthrough Device Designation
Annalise.ai received FDA 510(k) clearance for the triage and notification of obstructive hydrocephalus on non-contrast brain CT scans and was granted FDA Breakthrough Device Designation for this software tool. This marks the first radiology triage device to achieve Breakthrough status.
2023-09
Imaging Technology News
Study Shows Annalise Deep Learning System Boosts Radiologist Accuracy and Speed for Head CTs
A clinical study published in European Radiology demonstrated that radiologists assisted by Annalise.ai's deep learning system achieved significantly higher detection accuracy and interpreted cases faster for head CTs compared to unassisted radiologists.
2023-09
Business Wire
Annalise Enterprise Scores Big with Series of Regulatory Clearances
Annalise.ai achieved EU MDR and Singapore regulatory approvals for its Annalise Enterprise CXR chest X-ray solution, reaffirming its commitment to high safety and effectiveness standards in global healthcare markets.
2023-08
Harrison.ai
Annalise.ai grows global footprint with expansion into India
Annalise.ai announced its expansion into India with the opening of the Annalise India Centre in Chennai, aiming to leverage India's growing medical device market and diverse talent pool for new product development.
2023-05
Harrison.ai
Annalise.ai Builds Momentum in U.S. Market with Seven Additional FDA-Cleared Findings for Imaging Triage and Notification
Annalise.ai received seven additional FDA 510(k) clearances for its AI-assisted triage and notification solutions, bringing its total to nine FDA-cleared findings for Triage CT Brain and Triage Chest X-ray.
2023-04
Mass General Brigham News
Annalise.ai collaboration - Mass General Brigham News
Mass General Brigham and Annalise.ai announced a collaboration to develop and deploy AI-enabled diagnostic products, including the implementation of Annalise Triage across the Mass General Brigham system.
2023-11
MobiHealthNews
Harrison.ai snaps up $97M in Series B funding
Harrison.ai, the parent company of Annalise.ai, secured $97 million in Series B funding. This funding supports the development of new pathology AI tools and global expansion.
2021-12

Frequently Asked Questions

Annalise.ai provides AI-powered diagnostic support for a range of medical imaging modalities, including comprehensive chest X-ray (CXR) analysis and non-contrast head CT analysis. Their solutions are designed to assist in the detection of numerous conditions, such as pneumothorax, pleural effusion, various intracranial hemorrhages, and obstructive hydrocephalus, aiming to enhance diagnostic accuracy and efficiency.
Annalise.ai's AI-assisted triage and notification (CADt) system helps prioritize critical cases by rapidly identifying urgent findings on medical images, such as tension pneumothorax or acute subdural hematoma. This allows radiologists and healthcare administrators to optimize workflow by focusing on high-priority cases more quickly, potentially reducing turnaround times and improving patient outcomes.
Annalise.ai's products are CE Marked and TGA approved, and they have received FDA clearance for several of their AI algorithms, demonstrating their commitment to regulatory compliance. They offer comprehensive support to healthcare providers, including implementation assistance, ongoing technical support, and clinical education to ensure seamless integration and effective utilization of their AI solutions.
Annalise.ai's AI is trained to detect a broad spectrum of conditions, including orthopedic diseases like vertebral compression fractures on relevant imaging. While their primary focus has been on CXR and non-contrast head CT, their technology is continually evolving to address a wider range of medical concerns. For example, their CXR AI can detect up to 124 findings, including those related to respiratory tract diseases.
Annalise.ai typically offers flexible pricing models tailored to the needs of individual healthcare institutions, often based on usage or subscription. The company has strong partnerships with leading healthcare organizations and technology providers, including an exclusive global partnership with Philips, which contributes to their stability and fosters continuous innovation in their AI solutions.

Related Companies

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]

Koios Care is a neurology-focused digital medicine company based in Antwerp, Belgium, specializing in AI-powered platforms. The company aims to revolutionize the management of neurological and chronic conditions, with an initial focus on Parkinson’s Disease. Koios Care’s platform utilizes everyday devices like smartphones and smartwatches to passively collect and analyze data, transforming it into objective, […]

Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]

Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]

CortiCare is a healthcare AI company specializing in neuro telemetry and remote patient monitoring, primarily focusing on electroencephalogram (EEG) services. The company provides telehealth services and an EEG brain monitoring platform to neurology and critical care areas within hospitals, including ICUs, NICUs, PICUs, and EMUs. Their services aim to enhance the neurological assessment of adult, […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.